Micki Klearman

Trial of Tocilizumab in Giant-Cell Arteritis

John H. Stone, Katie Tuckwell, Sophie Dimonaco et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Cem Gabay, Paul Emery, Ronald van Vollenhoven et al. · The Lancet · 2013 · 673 citations

Life Sciences, Immunology, Pharmacotherapy +13

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics

Glynn Dennis, Cécile Holweg, Sarah Kummerfeld et al. · Arthritis Research & Therapy · 2014 · 373 citations · Full text

Medicine, Immunology, Internal Medicine +17

Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial

Jon T. Giles, Naveed Sattar, Sherine E. Gabriel et al. · Arthritis & Rheumatology · 2019 · 233 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study

Seoyoung C. Kim, Daniel H. Solomon, James R. Rogers et al. · Arthritis & Rheumatology · 2017 · 190 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17